BetterLife Pharma Inc. BETRF
OTC PK
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 794.40K | 393.80K | 273.00K | 271.90K | 371.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 842.10K | 409.50K | 315.20K | 280.50K | 372.40K |
| Operating Income | -842.10K | -409.50K | -315.20K | -280.50K | -372.40K |
| Income Before Tax | -1.50M | -446.90K | -275.20K | -302.80K | -366.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.50M | -446.90K | -275.20K | -302.80K | -366.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.90K | 2.50K | 800.00 | 8.00K | 7.00K |
| Net Income | -1.49M | -444.40K | -274.40K | -294.80K | -359.90K |
| EBIT | -842.10K | -409.50K | -315.20K | -280.50K | -372.40K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 162.32M | 154.43M | 151.50M | 151.86M | 149.71M |
| Average Diluted Shares Outstanding | 162.32M | 154.43M | 151.50M | 151.86M | 149.71M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |